Expression of Interest for Provision of Parenteral Methotrexate Services

Tender description

NHS Arden & Greater East Midlands Commissioning Support Unit (NHS Arden & GEM CSU) on behalf of NHS Derby and Derbyshire Clinical Commissioning Group are inviting Expressions of Interest from suitably qualified providers capable of providing Parenteral Methotrexate. The requirement will be for a 12-month contract (only) commencing 01st April 2022. The anticipated total value of the 12-month contract is £221,263. This value is based on the service cost (currently approximately 18% of the total contract value) and the drug cost (currently approximately 82% of the total current value). The service cost is paid by the CCG, the drug cost will be reimbursed via NHS BSA. This value is based on historical data and is not guaranteed. The contract may be terminated by the Commissioner at any time within the specified duration of the contract. The Commissioner will give 12 weeks' notice of cancellation to the provider in the event of this. The services will include dispensing and delivery of licensed parenteral methotrexate on an 8 weekly basis to patients, provision of clinical cytotoxic waste bins and clinical cytotoxic waste collection and disposal services..